Serenity Bioworks

Serenity Bioworks

Serenity Bioworks is an immune-compatible gene therapy company founded in 2017 by Cody Shirriff.

Serenity is developing an immunomodulatory platform called CargoTek. Their initial focus is to improve AAV gene therapy for monogenic diseases like hemophilia A, inherited retinal diseases and neurodegenerative diseases.

Funding

Seed

On June 22, 2018, Serenity Bioworks closed their Seed round. The amount raised was not disclosed. The round was led by SOSV, and IndieBio also participated in the seed funding round.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Cody Shirriff

Founder

Spencer Berg

Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.